Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$180M |
| 2 |
BHI
Baker Hughes
BHI
|
+$173M |
| 3 |
Dominion Energy
D
|
+$161M |
| 4 |
Kinder Morgan
KMI
|
+$155M |
| 5 |
Marathon Petroleum
MPC
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$177M |
| 2 |
SLB Ltd
SLB
|
+$121M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$119M |
| 4 |
PepsiCo
PEP
|
+$110M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 15.52% |
| 2 | Energy | 15.14% |
| 3 | Healthcare | 12.64% |
| 4 | Financials | 8.59% |
| 5 | Utilities | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
PUT
Palo Alto Networks
PANW
$312B
| $1.34M | ﹤0.01% |
+82,200
| New | +$1.18M |
|
|
CASC
2102
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.34M | ﹤0.01% |
116,667
+77,223
| +196% | +$1.18M |
|
2103
DexCom
DXCM
$33.7B
| $1.34M | ﹤0.01% |
134,152
-1,143,676
| -90% | -$11.7M |
|
2104
Genpact
G
$6.31B
| $1.34M | ﹤0.01% |
+81,990
| New | +$1.44M |
|
2105
First Merchants
FRME
$2.62B
| $1.34M | ﹤0.01% |
66,172
-144,242
| -69% | -$2.94M |
|
|
WINT
2106
DELISTED
Windtree Therapeutics Inc
WINT
| $1.34M | ﹤0.01% |
51,907
-73,093
| -58% | -$1.76M |
|
2107
Medallion Financial
MFIN
$271M
| $1.33M | ﹤0.01% |
114,377
-23,370
| -17% | -$278K |
|
|
IO
2108
DELISTED
ION Geophysical Corporation
IO
| $1.33M | ﹤0.01% |
31,861
+245
| +0.8% | +$13.1K |
|
2109
Ford
F
$55.6B
| $1.33M | ﹤0.01% |
+90,024
| New | +$1.54M |
|
2110
CRH
CRH
$63.6B
| $1.33M | ﹤0.01% |
58,259
-9,332
| -14% | -$225K |
|
2111
Agios Pharmaceuticals
AGIO
$2.05B
| $1.32M | ﹤0.01% |
+21,600
| New | +$931K |
|
2112
FormFactor
FORM
$8.61B
| $1.32M | ﹤0.01% |
184,733
+142,865
| +341% | +$1.06M |
|
2113
Orion
OEC
$354M
| $1.32M | ﹤0.01% |
+75,227
| New | +$1.31M |
|
2114
ICF International
ICFI
$1.61B
| $1.32M | ﹤0.01% |
42,985
+11,939
| +38% | +$410K |
|
2115
SouthState Bank Corp
SSB
$10.3B
| $1.32M | ﹤0.01% |
23,648
+19,709
| +500% | +$1.16M |
|
|
EPZM
2116
DELISTED
Epizyme, Inc
EPZM
| $1.32M | ﹤0.01% |
48,731
-15,009
| -24% | -$466K |
|
|
VG
2117
DELISTED
Vonage Holdings Corporation
VG
| $1.32M | ﹤0.01% |
402,496
-33,117
| -8% | -$115K |
|
2118
CALL
TJX Companies
TJX
$148B
| $1.31M | ﹤0.01% |
44,400
+2,000
| +5% | +$56.4K |
|
|
LOXO
2119
DELISTED
Loxo Oncology, Inc
LOXO
| $1.31M | ﹤0.01% |
+100,000
| New | +$1.3M |
|
2120
Central Pacific Financial
CPF
$974M
| $1.31M | ﹤0.01% |
73,061
+34,426
| +89% | +$631K |
|
2121
Diageo
DEO
$51.2B
| $1.31M | ﹤0.01% |
11,334
-93,430
| -89% | -$11.3M |
|
2122
MannKind Corp
MNKD
$1.31B
| $1.3M | ﹤0.01% |
44,170
+37,875
| +602% | +$1.49M |
|
2123
PUT
iShares MSCI Brazil ETF
EWZ
$8.2B
| $1.3M | ﹤0.01% |
30,000
| – | – |
|
2124
Murphy Oil
MUR
$5.15B
| $1.3M | ﹤0.01% |
22,915
-114,620
| -83% | -$7.09M |
|
2125
Domino's
DPZ
$11B
| $1.3M | ﹤0.01% |
16,922
-60,113
| -78% | -$4.48M |
|
Similar funds
Israel Englander's Q3 2014 Portfolio in Review
As of Q3 2014, Israel Englander held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander deployed $4.26B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 16% of assets, up from 14% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.
- Israel Englander's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
- Israel Englander added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
- Israel Englander's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
- Israel Englander fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
- Israel Englander opened 1,066 new positions and closed 749 in Q3 2014.
- Israel Englander's portfolio value rose 9.5% quarter-over-quarter to $39.5B.
Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.